Allen Lapey

Dual SMAD Signaling Inhibition Enables Long-Term Expansion of Diverse Epithelial Basal Cells

Hongmei Mou, Vladimir Vinarsky, Purushothama Rao Tata et al. · Cell stem cell · 2016 · 402 citations · Full text

Cell Lineage, Developmental Biology, Molecular Physiology +8

Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study

Jane C. Davies, Steve Cunningham, William T. Harris et al. · The Lancet Respiratory Medicine · 2016 · 339 citations · Full text

Single-arm Study, Pathology, Pulmonary Fibrosis +2

Generation of Multipotent Lung and Airway Progenitors from Mouse ESCs and Patient-Specific Cystic Fibrosis iPSCs

Hongmei Mou, Rui Zhao, Richard I. Sherwood et al. · Cell stem cell · 2012 · 322 citations · Full text

Population-Based Newborn Screening for Genetic Disorders When Multiple Mutation DNA Testing Is Incorporated: A Cystic Fibrosis Newborn Screening Model Demonstrating Increased Sensitivity but More Carrier Detections

Anne Marie Comeau, Richard B. Parad, Henry L. Dorkin et al. · PEDIATRICS · 2004 · 154 citations

An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2–5 years (KLIMB)

Margaret Rosenfeld, Steve Cunningham, William T. Harris et al. · Journal of Cystic Fibrosis · 2019 · 128 citations · Full text